Partnerships and Collaboration
To fulfill its mission to monitor and ensure the safety of the supply chain for food, feed, medical products, cosmetics, and tobacco products that enter the United States from other parts of the world, the FDA engages in partnerships with foreign governments, regulatory coalitions, development organizations, academic institutions, among others.
FDA's International Partnership Focus Areas
Strong regulatory systems are critical to any well-functioning health system. The FDA is focused on three interrelated areas in support of RSS:
- catalyzing a global dialogue on the importance of regulatory systems to public health;
- collaborating with others to identify effective approaches to strengthen systems; and
- leveraging global health and development resources.
We engage with a variety of partners in the area of RSS, including:
- Pan American Health Organization (PAHO) regulatory systems strengthening
- International Conference of Drug Regulatory Authorities (ICDRA)
- International Coalition of Medicines Regulatory Authorities (ICMRA)
- Pan American Network for Drug Regulatory Harmonization (PANDRH)
- U.S. President's Emergency Plan for AIDS Relief (PEPFAR)
The FDA advocates for stronger safety surveillance systems globally, including drug and vaccine safety systems, as well as systems to detect substandard and falsified products. The Office of International Programs works closely with key FDA Centers to advance thinking in these areas where appropriate:
The FDA advocates for stronger food safety systems globally, including through multilateral organizations. The Office of International Programs works closely with key FDA Centers to support FDA priorities in these areas:
- Public Meeting in Mexico City, Mexico, for Industry, Consumer Groups and Other Interested Stakeholders on Final Rules for the United States (U.S.) Food Safety Modernization Act (FSMA) (April 2016)
- World Bank Global Food Safety Partnership (GFSP)
- FDA Food Safety Modernization Act (FSMA) International Capacity Building Plan
- Increasing Oversight of API Manufacturing Through International Collaboration (December 2018)
- EC/EMA-FDA Bilateral - Update, July 13, 2015 (PDF - 64KB)
- EMA-EU MSs-FDA initiative on inspections (PDF - 70KB)
- Guiding principles for the international pharmacovigilance cluster, 22 May 2015 Rev 1 (PDF - 70KB)
- Joint Initiatives and Global Collaborations with the European Medicines Agency
- Transatlantic Economic Council High Level Regulatory Cooperation Forum
- Transatlantic Task Force on Antimicrobial Resistance
International Arrangements
Recalls & Alerts
- Recalls, Market Withdrawals, & Safety Alerts
- MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- Warning Letters
- FDA Recall Information on Twitter
Resources For You
- FDA Globalization
- Imports and Exports
- International Arrangements
- News and Events
- President's Emergency Plan for AIDS Relief (PEPFAR)